GHP Family formulary changes take effect Oct. 1

Be advised of the following updates to the GHP Family formulary:

• Topical Tretinoin (Generic Retin-A):
  Generic topical tretinoin cream will be the preferred product. Retin-A brand will no longer be covered. An age restriction will apply to topical tretinoin.
• Xifaxan:
  Xifaxan 550 mg tablets will no longer be covered.
  Xifaxan 200 mg tablets for the treatment of hepatic encephalopathy will require prior authorization. If switching from 550 mg to 200 mg, a new prescription and prior authorization will be required.